Streetbeat News

Stock Prices

ORCL

Oracle Inc.'s shares are trading at $107.00, after a 1.25% decrease. Over the past month, the stock fell by 15.29%, but over the past year, it increased by 71.89%. Oracle's P/E ratio is 32.15, lower than the Software industry average of 68.77, which could indicate that the stock is undervalued or has weak growth prospects.

Portfolio Pulse from Benzinga Insights

October 06, 2023 | 1:00 pm

AES

In the last quarter, AES (NYSE:AES) has received four somewhat bullish ratings and one indifferent rating from analysts. The average 12-month price target for AES is $23.8, a decrease of 11.85% from the previous average of $27.00.

Portfolio Pulse from Benzinga Insights

October 06, 2023 | 1:00 pm

KMI

Four analysts have provided ratings for Kinder Morgan (NYSE:KMI) in the last quarter, with one being bullish, two indifferent, and one somewhat bearish. The average price target is $20.75, representing an upside from the current price of $16.18. This average is a 1.19% decrease from the previous average price target of $21.00.

Portfolio Pulse from Benzinga Insights

October 06, 2023 | 1:00 pm

STRO

Sutro Biopharma (NASDAQ:STRO) has received 5 analyst ratings in the last quarter, with 2 being bullish and 3 somewhat bullish. The average price target is $16.0, representing a significant upside from the current price of $3.59. However, this average represents a 20.0% decrease from the previous average price target of $20.00.

Portfolio Pulse from Benzinga Insights

October 06, 2023 | 1:00 pm

EPD

In the last quarter, Enterprise Prods Partners (NYSE:EPD) received 2 bullish and 2 indifferent analyst ratings. The company has an average 12-month price target of $32.0, representing a 3.99% decrease from the previous average price target of $33.33.

Portfolio Pulse from Benzinga Insights

October 06, 2023 | 1:00 pm

KIRK

LIXT

VANI

Insiders at Kirkland's, Inc. (KIRK), Vivani Medical, Inc. (VANI), and Lixte Biotechnology Holdings, Inc. (LIXT) have recently purchased shares in their respective companies. This comes after Kirkland's reported weaker-than-expected Q2 FY23 results, Vivani Medical posted a wider-than-expected Q2 loss, and Lixte Biotechnology's stock fell around 73% over the past six months.

Portfolio Pulse from Lisa Levin

October 06, 2023 | 12:59 pm

NVNO

enVVeno Medical Corporation (NASDAQ:NVNO) has announced a private placement of $28 million, conducted as an at-the-market offering under Nasdaq rules. The transaction was led by Perceptive Advisors, Nantahala Capital, Kingdon Capital Management, Velan Capital, L1 Capital and other institutional investors. The company could receive up to an additional $75 million from milestone-driven warrants upon the release of initial topline efficacy data from the VenoValve pivotal trial and FDA pre-market approval of the VenoValve.

Portfolio Pulse from Benzinga Newsdesk

October 06, 2023 | 12:58 pm

PRZO

ParaZero shares are trading higher after the Australian regulator, the Civil Aviation Safety Agency, approved the first commercial drone flights in populated areas and near people using ParaZero safety systems.

Portfolio Pulse from Benzinga Newsdesk

October 06, 2023 | 12:58 pm

AEHR

Aehr Test Systems (AEHR) reported its Q1 financial results, following which its shares traded lower.

Portfolio Pulse from Benzinga Newsdesk

October 06, 2023 | 12:57 pm

CRWD

FTV

PXD

XOM

On CNBC's 'Halftime Report Final Trades', ExxonMobil Corporation was mentioned for its 3.2% dividend yield and share buyback. ExxonMobil is reportedly acquiring Pioneer Natural Resources Co. for approximately $60 billion. Fortive Corporation was named by Karen Firestone of Aureus Asset Management, highlighting its Q2 sales growth of 4.3% YoY. Joshua Brown of Ritholtz Wealth Management picked CrowdStrike Holdings, Inc., which recently launched cybersecurity's first zero-code application development platform.

Portfolio Pulse from Priya Nigam

October 06, 2023 | 12:55 pm